Synlogic reports first quarter financial results and provides business update

Cambridge, mass., may 13, 2021 /prnewswire/ -- synlogic, inc. (nasdaq: sybx), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financial results for the first quarter ended march 31, 2021, and provided an update on its clinical and preclinical programs.
SYBX Ratings Summary
SYBX Quant Ranking